info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

CommentaryOpen Access

Epigenetics and Carcinogenesis: DNA Methylation Abnormalities Associated with Cancer and their Possible Source

Volume 2 - Issue 3

Patrick A Riley*

  • Author Information Open or Close
    • Totteridge Institute for Advanced Studies, Grange Avenue, London

    *Corresponding author: Patrick A Riley, Totteridge Institute for Advanced Studies, The Grange, Grange Avenue, London

Received: February 07, 2018;   Published: February 19, 2018

DOI: 10.26717/BJSTR.2018.02.000772

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

It is now well-established that the majority of the aberrant gene expression profiles described in human cancers are due to epigenetic changes. These patterns reflect DNA methylation changes, including both hypo- and hypermethylation. There is evidence to suggest that, in general, hypomethylation is associated with the expression of previously silenced genes whereas DNA hypermethylation is involved in the silencing of previously transcribed genes and there has been much interest in the inhibition of tumour-suppressor genes as a possible carcinogenic mechanism. This brief overview discusses the possible origins of the observed anomalies of DNA methylation and proposes that the initiating carcinogenic mechanism lies in the failure of accurate copying of the epigenetic pattern during stem cell proliferation.

Keywords: DNA Methylation; Cancer; Epigenetics

Introduction| DNA Hypomethylation| Possible Mechanisms of Demethylation| DNA Hypermethylation| Acknowledgement| References|